{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458273599
| drug_name = Indium (<sup>111</sup>In) altumomab pentetate
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = o
| target = [[Carcinoembryonic antigen|CEA]]
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 156586-92-4
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}

'''Indium (111In) altumomab pentetate''' ([[International Nonproprietary Name|INN]]) ([[United States Pharmacopeia|USP]], indium In 111 altumomab pentetate; trade name '''Hybri-ceaker''') is a [[mouse]] [[monoclonal antibody]] linked to [[pentetate]] which acts as a [[chelating agent]] for the [[radioisotope]] [[indium-111]]. The drug is used for the diagnosis of [[colorectal cancer]].<ref>[http://whqlibdoc.who.int/inn/INN_1993_list33.pdf WHO Drug Information]</ref><ref>[https://www.scribd.com/doc/1440358/US-Food-and-Drug-Administration-list FDA]</ref>

==References==
{{reflist}}

{{Monoclonals for tumors}}

[[Category:Monoclonal antibodies for tumors]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}